Clear Harbor Asset Management, LLC Paratek Pharmaceuticals, Inc. Transaction History

Clear Harbor Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$4.58 - $7.14 $3,801 - $5,926	-830 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$4.19 - $6.69 $3,477 - $5,552	830 New	830 $4,000
Q1 2020 May 08, 2020	SELL	$2.67 - $4.97 $934 - $1,739	-350 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$2.93 - $4.5 $1,025 - $1,575	350 New	350 $1,000
Q3 2018 Oct 26, 2018	SELL	$9.05 - $10.95 $136,826 - $165,553	-15,119 Closed	0 $0
Q2 2018 Aug 03, 2018	BUY	$10.2 - $13.9 $154,213 - $210,154	15,119 New	15,119 $154,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.